Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Ken Beng Chye Lee Insider Profile
4 Followers
Ken Beng Chye Lee, Managing Director, Ten Percent Owner at Argent Biopharma, holds 19.72M shares in Argent Biopharma (Ticker: RGTLF). Most recently, Ken Beng Chye Lee ― shares of Argent Biopharma on ― for an estimated value of ―.
Ken Beng Chye Lee has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Ken Beng Chye Lee's holdings
Insider Roles
Managing Director, Ten Percent Owner
Roles that Ken Beng Chye Lee holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Ken Beng Chye Lee
Ken Beng Chye Lee's Trading History
List of latest transactions for each holding click on a transaction to see Ken Beng Chye Lee's performance on stock
You May Also Like
Ken Beng Chye Lee insider profile FAQ
What is the percentage of profitable transactions made by Ken Beng Chye Lee?
The percentage of profitable transactions made by Ken Beng Chye Lee is ―.
What is the average return per transaction made by Ken Beng Chye Lee?
The average return per transaction made by Ken Beng Chye Lee is ―.
What stocks does Ken Beng Chye Lee hold?
Ken Beng Chye Lee holds: RGTLF stocks.
What was Ken Beng Chye Lee’s latest transaction?
Ken Beng Chye Lee latest transaction was an Uninformative Buy of ―.
What was Ken Beng Chye Lee's most profitable transaction?
Ken Beng Chye Lee’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Ken Beng Chye Lee's role in Argent Biopharma?
Ken Beng Chye Lee's role in Argent Biopharma is Managing Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.